SmartContrast AI-Powered
Contrast Agent Reduction

SmartContrast uses AI to reduce gadolinium contrast agent usage while maintaining full diagnostic image quality. Use just 1/3rd of the standard dose and let AI enhance the output to match full-dose quality.

🛡️

Safer for Patients

💉

Substantial Cost Savings

✨

Environmentally Friendly

Research Stage: SmartContrast has shown promising results in clinical research and is currently undergoing the regulatory processes required for clinical use.

GET IN TOUCH

See SmartContrast in Action

AI-based Contrast Agent Reduction

SmartContrast Benefits

Reducing gadolinium contrast agent usage while maintaining diagnostic quality

Reduced Contrast Agent

67% dose reduction

Use only 33% of standard gadolinium dose to achieve substantial cost savings.

AI-Powered Enhancement

Full diagnostic quality

Advanced deep learning algorithms enhance low-dose images to match the diagnostic quality of full-dose scans.

Improved Patient Safety

Better patient outcomes

Lower contrast agent usage reduces risks for patients with renal impairment or gadolinium sensitivity.

Environmentally Friendly

Sustainable healthcare

Cuts environmental impact by reducing gadolinium release into waterways and minimizing contamination of ecosystems.

Advantages of AI-based contrast enhancement

„In all patients use the smallest amount of contrast medium necessary for a diagnostic result.“

- ESUR Guidelines

  1. Picture of a scan of a skull.
Item 1 of 3

Key aspects of our AI-based contrast enhancement solution

  1. Diagnostic equivalence

Item 1 of 4

Interested in SmartContrast?

While SmartContrast is not yet available for clinical use, we'd love to hear from you. Get in touch to learn more about our research and future availability.

GET IN TOUCH